Chromatography and capillary electrophoresis in modelling the basic processes of drug action

TrAC - Trends in Analytical Chemistry

Volumn 18, Issue 6, 1999, Pages 400-410

  Kaliszan, Roman ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Biochromatography; Chemometrics; Drug drug interaction; Drug protein interaction; Drug receptor interaction; Hydrophobicity; Linear free energy relationship; Lipophilicity; Pharmacodynamics; Pharmacokinetics; Pharmacological receptor; Principal component analysis; Quantitative structure retention relationship; Serum protein; Skin permeation

Indexed keywords

ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; PHENOTHIAZINE; PHENYLBUTAZONE; PSYCHOTROPIC AGENT;

CAPILLARY ELECTROPHORESIS; CHEMOMETRIC ANALYSIS; CHROMATOGRAPHY; DRUG INTERACTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; LIPOPHILICITY; METHODOLOGY; MODEL; PHARMACODYNAMICS; PHARMACOKINETICS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SKIN PERMEABILITY;

EID: 0032979527     PISSN: 01659936     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-9936(99)00120-X     Document Type: Article

References (49)

1. E. Mutschler and H. Derendorf, Drug Actions, Medpharm, Stuttgart, 1995.
2. R. Kaliszan, Structure and Retention in Chromatography. A Chemometric Approach, Harwood Academic Publishers, Amsterdam, 1997.
3. P.W. Carr, D.E. Martire and L.R. Snyder (Editors), The Retention Process in Reversed-Phase Liquid Chromatography, J. Chromatogr. A, Special Volume 656 (1993) 1.
4. Khaledi M.G. Trends Anal. Chem. 7:1988;293.
5. Terabe S., Otsuka K., Ichikawa K., Tsuchiya A., Ando T. Anal. Chem. 56:1984;111.
6. Dorsey J.G. Adv. Chromatogr. 27:1987;167.
7. Gao J., Mammen M., Whitesides G.W. Science. 272:1996;535.
8. Oravcová J., Böhs B., Lindner W. J. Chromatogr. A. 677:1996;1.
9. Shibukawa A., Nakagawa T. Anal. Chem. 68:1996;447.
10. Hage D.S., Tweed S.A. J. Chromatogr. B. 699:1997;499.
11. R. Kaliszan and I.W. Wainer, in K. Jinno (Editor), Chromatographic Separations Based on Molecular Recognition, Wiley-VCH, New York, 1997, p. 273.
12. Lloyd D.K., Aubry A.-F., De Lorenzi E. J. Chromatogr. A. 792:1997;349.
13. Kaliszan R. Anal. Chem. 64:1992;619.
14. A.R. Kaliszan, Quantitative Structure-Chromatographic Retention Relationships, Wiley, New York, 1987.
15. E. Forgács and T. Cserháti, Molecular Bases of Chromatographic Separations, CRC Press, Boca Raton, FL, 1997.
16. Hansch C., Fujita T. J. Am. Chem. Soc. 86:1964;1616.
17. P.N. Craig, in C. Hansch, P.G. Sammes and J.B. Taylor (Editors), Comprehensive Medicinal Chemistry, Vol. 6, Pergamon Press, Oxford, 1990.
18. V. Pliška, B. Testa and H. van de Waterbeemd (Editors), Lipophilicity in Drug Action and Toxicology, VCH, Weinheim, 1996.
19. Ong S., Pidgeon C. Anal. Chem. 67:1995;2119.
20. Kaliszan R., Kaliszan A., Wainer I.W. J. Pharm. Biomed. Anal. 11:1993;505.
21. Abraham M.H., Chadha H.S., Leitao R.A.E., Mitchell R.C., Lambert W.J., Kaliszan R., Nasal A., Haber P. J. Chromatogr. A. 766:1997;35.
22. Ducarme A., Neuwels M., Goldstein S., Massingham R. Eur. J. Med. Chem. 32:1997;226.
23. Pidgeon C., Ong S., Lin H., Qiu X., Pidgeon M., Dantzig A.H., Munroe J., Hornback W.J., Kasker J.S., Glunz L., Szczerba T. J. Med. Chem. 38:1995;590.
24. Nasal A., Sznitowska M., Buciñski A., Kaliszan R. J. Chromatogr. A. 692:1995;83.
25. Kaliszan R., Nasal A., Buciñski A. Eur. J. Med. Chem. 29:1994;163.
26. Barbato F., La Rotonda M.I., Quaglia F. J. Pharm. Sci. 86:1997;225.
27. Cohen D.E., Leonard M.R. J. Lipid Res. 36:1995;2251.
28. Yang S., Bumgarner J.G., Kruk L.F.R., Khaledi M.G. J. Chromatogr. A. 721:1996;323.
29. Noctor T.A.G., Diaz-Perez M.J., Wainer I.W. J. Pharm. Sci. 82:1993;675.
30. Busch M.H.A., Kraak J.C., Poppe H. J. Chromatogr. A. 777:1997;329.
31. Kaliszan R., Noctor T.A.G., Wainer I.W. Mol. Pharmacol. 42:1992;512.
32. Kaliszan R., Nasal A., Turowski M. J. Chromatogr. A. 722:1996;25.
33. Schley J. J. Pharm. Pharmacol. 39:1987;132.
34. Soltes L., Sebille B., Szalay P. J. Pharm. Biomed. Anal. 12:1994;1295.
35. El Tayar N., Tsai R.-S., Testa B., Carrupt P.-A., Hansch C., Leo A. J. Pharm. Sci. 80:1991;744.
36. Turowski M., Kaliszan R. J. Pharm. Biomed. Anal. 15:1997;1325.
37. Turowski M., Kaliszan R. Biomed. Chromatogr. 12:1998;187.
38. Noctor T.A.G., Wainer I.W., Hage D.S. J. Chromatogr. 577:1992;305.
39. Noctor T.A.G., Wainer I.W. J. Liq. Chromatogr. 16:1993;783.
40. Aubry A.-F., Markoglou N., McGann A. Comp. Biochem. Physiol. 112C:1995;257.
41. Lloyd D.K., Li S., Ryan P. J. Chromatogr. A. 694:1995;285.
42. M. Markuszewski and R. Kaliszan, to be published.
43. S. Wold, C. Albano, W.J. Dunn III, U. Edlund, K. Esbensen, P. Geladi, S. Hellberg, E. Johansson, W. Lindberg and M. Sjöström, in B.R. Kowalski (Editor), Chemometrics, Reidel, Dordrecht, 1984, p. 17.
44. Anthony M.L., Sweatman B.C., Beddell C.R., Lindon J.C., Nicholson J.K. Mol. Pharmacol. 46:1994;199.
45. Damborsky J. Quant. Struct.-Act. Relat. 16:1997;126.
46. Eriksson L., Jonsson J., Sjöström M., Wold S. Quant. Struct.-Act. Relat. 7:1988;144.
47. Gami-Yilinkou R., Kaliszan R. J. Chromatogr. 550:1991;573.
48. Nasal A., Buciński A., Bober L., Kaliszan R. Int. J. Pharm. 159:1997;43.
49. Goolkasian D.L., Slaughter R.L., Edwards D.J., Lalka D. Eur. J. Clin. Pharmacol. 25:1983;413.